Skip to main content

nbtxr3

nbtxr3: sourced relationships with 1 company · 2 clinical trials tracked.

nbtxr3 evidence translation

What we can confirm

2 tracked trials

What it means

Source-backed records connect nbtxr3 to LIANY; that link alone does not prove the drug works.

What to watch

Watch trial status, endpoints, and the next source-backed update.
BioSniper AIPage evidence connected

Prepared research question

How could nbtxr3 → LIANY affect its developer, and what evidence supports the link?

Run cited research

Traceable citations · Unknowns marked

See linked entities and source evidence2 indications · 0 study sponsors

Related indications

locally advanced head and neck ("H&N") squamous cell carcinomaMetastatic Renal Cell Carcinoma

Study sponsors

No additional listed-company sponsor is linked.

Dated Pipeline Records (1)
CompanyDated record stage
LianBio (LIANY)
developer · Reported 2023-03-28 · Current development: unknownSource
locally advanced head and neck ("H&N") squamous cell carcino…
Phase 3
Clinical Trial Registry Records (2)

NBTXR3 With Radiation Therapy Alone for Locally-advanced Non-small Cell Lung Cancer

NCT07224152Registry updated 2026-09-18·Phase 1/Phase 2
Recruiting

Primary endpoint: Safety and Adverse Events (AEs)

Interventionalopen40 targetStarted 2026-03Completion 2030-081 site · United StatesM.D. Anderson Cancer Center

A Phase I Dose Escalation / Dose Expansion Study of NBTXR3 Activated by Radiotherapy for Patients With Advanced Cancers Treated With An Anti-PD-1 Therapy

NCT03589339Registry updated 2025-10-24·Phase 1
Active, not recruiting

Primary endpoint: [Dose Escalation Part]: Determination of the Recommended Dose

Interventionalopen145 targetStarted 2019-01Completion 2027-0813 sites · United StatesNanobiotix

Frequently asked questions

Which companies have sourced relationships with nbtxr3?

nbtxr3 has dated SEC/FDA relationship records for LianBio.

How many clinical trials involve nbtxr3?

BioSniper tracks 2 clinical trials involving nbtxr3.